The CBC analysis of peripheral blood at 3 months post-BMT from TMI (8:2)-treated mice showed a significant improvement in RBC numbers, Hb content, and platelets compared to the age- and sex-matched untreated SS mice (Figure 6A). The gene discussed is GSTM1; the disease is synovial sarcoma.